Consensus Statement from India on the Renal Benefits of ARNi, SGLT-2i, and Bisoprolol in Chronic Kidney Disease.
印度有關 ARNi、SGLT-2i 和 Bisoprolol 對慢性腎臟病的腎臟益處共識聲明。
J Assoc Physicians India 2024-06-17
An Updated Review of the Management of Chronic Heart Failure in Patients with Chronic Kidney Disease.
慢性腎病患者慢性心衰竭管理的最新回顧。
Rev Cardiovasc Med 2024-07-30
The impact of angiotensin-receptor neprilysin inhibitors on cardiovascular events and solute transport function in peritoneal dialysis patients: a multicenter retrospective controlled study.
血管緊張素受體中性肽酶抑制劑對腹膜透析患者心血管事件及溶質運輸功能的影響:一項多中心回顧性對照研究。
Ren Fail 2024-11-29
Impact of Renin-Angiotensin-Aldosterone System Inhibition on Advanced Chronic Kidney Disease Progression - a Retrospective Observational Study.
腎素-血管緊張素-醛固酮系統抑制對於晚期慢性腎病進展的影響 - 一項回顧性觀察研究。
Am J Nephrol 2025-02-26
Cardiorenal benefits of SGLT2 inhibitors in patients with chronic kidney disease and concomitant hypertension.
SGLT2 抑制劑在合併高血壓的慢性腎臟病患者中的心腎益處
Cardiorenal Med 2025-04-21